JEMI vs. WWH, FEV, VEIL, PNL, WTAN, BRW, JTC, PIN, SNN, and BHMU
Should you be buying JPMorgan Global Emerg Mkts stock or one of its competitors? The main competitors of JPMorgan Global Emerg Mkts include Worldwide Healthcare (WWH), Fidelity European Trust (FEV), Vietnam Enterprise (VEIL), Personal Assets (PNL), Witan Investment Trust (WTAN), Brewin Dolphin (BRW), JTC (JTC), Pantheon International (PIN), Sanne Group (SNN), and BH Macro USD (BHMU). These companies are all part of the "asset management" industry.
JPMorgan Global Emerg Mkts vs. Its Competitors
Worldwide Healthcare (LON:WWH) and JPMorgan Global Emerg Mkts (LON:JEMI) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.
In the previous week, Worldwide Healthcare had 3 more articles in the media than JPMorgan Global Emerg Mkts. MarketBeat recorded 4 mentions for Worldwide Healthcare and 1 mentions for JPMorgan Global Emerg Mkts. Worldwide Healthcare's average media sentiment score of 1.66 beat JPMorgan Global Emerg Mkts' score of 0.67 indicating that Worldwide Healthcare is being referred to more favorably in the media.
73.6% of Worldwide Healthcare shares are owned by institutional investors. Comparatively, 56.3% of JPMorgan Global Emerg Mkts shares are owned by institutional investors. 0.4% of Worldwide Healthcare shares are owned by insiders. Comparatively, 3.7% of JPMorgan Global Emerg Mkts shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Worldwide Healthcare has a net margin of 92.78% compared to JPMorgan Global Emerg Mkts' net margin of 72.95%. Worldwide Healthcare's return on equity of 11.22% beat JPMorgan Global Emerg Mkts' return on equity.
Worldwide Healthcare pays an annual dividend of GBX 3 per share and has a dividend yield of 0.9%. JPMorgan Global Emerg Mkts pays an annual dividend of GBX 5 per share and has a dividend yield of 3.3%. Worldwide Healthcare pays out 7.0% of its earnings in the form of a dividend. JPMorgan Global Emerg Mkts pays out 56.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Worldwide Healthcare has higher revenue and earnings than JPMorgan Global Emerg Mkts. Worldwide Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Global Emerg Mkts, indicating that it is currently the more affordable of the two stocks.
Summary
Worldwide Healthcare beats JPMorgan Global Emerg Mkts on 9 of the 14 factors compared between the two stocks.
Get JPMorgan Global Emerg Mkts News Delivered to You Automatically
Sign up to receive the latest news and ratings for JEMI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JEMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
JPMorgan Global Emerg Mkts Competitors List
Related Companies and Tools
This page (LON:JEMI) was last updated on 8/15/2025 by MarketBeat.com Staff
MarketBeat All Access